Edwards Lifesciences Corporation Net Income (Loss) Attributable to Noncontrolling Interest
Edwards Lifesciences Corporation (EW) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-04
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$500.00K.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $0.00.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$800.00K.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$4.10M.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$4.90M.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$3.00M.
- Edwards Lifesciences Corporation net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$500.00K 10-Q · filed 2026-08-04 | -$500.00K 10-Q · filed 2026-08-04 | -$500.00K derived: sum of 3 quarters · filed 2026-08-04 | -$1.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | -$800.00K derived: sum of 3 quarters · filed 2026-05-06 | -$2.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$800.00K derived: sum of 2 quarters · filed 2026-02-25 | -$2.50M derived: sum of 3 quarters · filed 2026-08-04 | -$4.10M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$800.00K 10-Q · filed 2025-11-05 | -$2.50M derived: sum of 2 quarters · filed 2026-08-04 | -$4.10M 10-Q · filed 2025-11-05 | -$5.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$1.70M 10-Q · filed 2026-08-04 | -$3.30M 10-Q · filed 2026-08-04 | -$4.60M derived: sum of 3 quarters · filed 2026-08-04 | -$6.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-06 | -$2.90M derived: sum of 2 quarters · filed 2026-05-06 | -$4.30M derived: sum of 3 quarters · filed 2026-05-06 | -$5.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.70M derived: sum of 2 quarters · filed 2026-02-25 | -$4.00M derived: sum of 3 quarters · filed 2026-02-25 | -$4.90M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$1.40M 10-Q · filed 2025-11-05 | -$2.70M derived: sum of 2 quarters · filed 2025-11-05 | -$3.60M 10-Q · filed 2025-11-05 | -$3.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$1.30M 10-Q · filed 2025-08-06 | -$2.20M 10-Q · filed 2025-08-06 | -$2.40M derived: sum of 3 quarters · filed 2026-02-25 | -$3.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$900.00K 10-Q · filed 2025-05-06 | -$1.10M derived: sum of 2 quarters · filed 2026-02-25 | -$2.30M derived: sum of 3 quarters · filed 2026-02-25 | -$3.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.40M derived: sum of 2 quarters · filed 2026-02-25 | -$3.00M derived: sum of 3 quarters · filed 2026-02-25 | -$3.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.20M 10-Q · filed 2024-11-06 | -$2.80M derived: sum of 2 quarters · filed 2024-11-06 | -$2.80M 10-Q · filed 2024-11-06 | -$2.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$1.60M 10-Q · filed 2024-07-31 | -$1.60M 10-Q · filed 2024-07-31 | -$1.60M derived: sum of 3 quarters · filed 2025-02-28 | -$1.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |